Pablo Kizelsztein Selected Research

Demyelinating Diseases (Demyelinating Disease)

12/2009

Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pablo Kizelsztein Research Topics

Disease

2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015 - 08/2009
2	Insulin Resistance 09/2012 - 03/2009
2	Hyperglycemia 09/2012 - 03/2009
2	Body Weight (Weight, Body) 09/2012 - 03/2009
2	Obesity 09/2012 - 03/2009
2	Multiple Sclerosis 12/2009 - 08/2009
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2009 - 08/2009
1	Neuroinflammatory Diseases 01/2015
1	Hepatocellular Carcinoma (Hepatoma) 09/2012
1	Inflammation (Inflammations) 12/2009
1	Demyelinating Diseases (Demyelinating Disease) 12/2009
1	Parkinson Disease (Parkinson's Disease) 08/2009
1	Carcinoma (Carcinomatosis) 02/2007

Drug/Important Bio-Agent (IBA)

2	Liposomes (Liposome)IBA 01/2015 - 02/2007
1	Bulk DrugsIBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2012
1	Cyclic AMP (AMP, Cyclic)IBA 09/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2012
1	Messenger RNA (mRNA)IBA 09/2012
1	triptolideIBA 12/2009
1	NF-KappaB Inhibitor alphaIBA 12/2009
1	NF-kappa B (NF-kB)IBA 12/2009
1	AntioxidantsIBA 08/2009
1	4-amino-TEMPO (A-TEMPO)IBA 08/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2009
1	Ecdysterone (20 Hydroxyecdysone)IBA 03/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2007

Therapy/Procedure

2	Oral Administration 12/2009 - 03/2009
1	Injections 12/2009
1	Therapeutics 08/2009